BACKGROUND: Arterial pulse pressure hypertension is associated with perioperative morbidity and mortality in cardiac surgery patients. However, its association with perioperative mortality in other high-risk surgical populations has not been determined. In this study, we tested the hypothesis that increased preoperative arterial pulse pressure is associated with 30-day and 1-year all-cause mortality after lower extremity arterial bypass surgery. METHODS: A retrospective review of patients who had infrainguinal arterial bypass surgery at a single center over a 6-year period (January 2002 to January 2008) was performed (n ϭ 556). Mean, systolic, and diastolic arterial blood pressure were determined from a single noninvasive oscillometric blood pressure cuff reading in the operating room before the administration of anesthetic drugs. Pulse pressure was calculated from this measurement in a retrospective manner by subtracting diastolic pressure from systolic pressure. Mortality for all subjects was determined using the social security death index. Comorbid conditions, preoperative medications, and anesthetic techniques were recorded. Univariate and multivariate analyses were performed to evaluate the association between arterial pulse pressure and the primary outcome variables, and all-cause 30-day and 1-year mortality. RESULTS: Of the 556 patients, a large percentage had elevated pulse pressure (44.9% had pulse pressure Ն80). Thirty-day mortality was 5.1% and 1-year mortality was 17.8%. There was no apparent association between preoperative pulse pressure and 30-day (P ϭ 0.35) or 1-year (P ϭ 0.14) all-cause mortality. Independent predictors of 30-day mortality were age Ն80 years (P ϭ 0.02), ASA physical status ՆIV (P ϭ 0.04), baseline creatinine Ͼ2.0 mg/dL (P Ͻ 0.0001), and emergency surgery (P ϭ 0.009). The same variables were associated with 1-year mortality, as were the Lee's Revised Cardiac Risk Index score, female gender, and gangrene or ulcer as an indication for surgery. CONCLUSION: Our results suggest that increased preoperative arterial pulse pressure might not be associated with all-cause mortality after lower extremity arterial bypass surgery.
S ystolic and diastolic hypertension are recognized risk factors for myocardial infarction, congestive heart failure, stroke, and death. 1 Elevated pulse pressure, measured as the difference between systolic and diastolic pressure, has also been recognized as a strong independent risk factor for cardiovascular disease and death. In fact, large population-based prospective studies suggest that chronic pulse pressure hypertension is more strongly associated with cardiovascular risk than either systolic or diastolic hypertension over time even after adjusting for other risk factors. [2] [3] [4] Pulse pressure hypertension has also been specifically studied as a risk factor in elderly patients.
In several large population-based studies that included only elderly patients, increased pulse pressure independently predicted cardiovascular complications and cardiovascular mortality. [5] [6] [7] Pulse pressure hypertension has been identified as a risk factor for cardiovascular disease even in patients who do not have systolic or diastolic hypertension, suggesting it is a unique risk factor. 7 Elevated pulse pressure has been found to be predictive of adverse events after coronary artery bypass graft (CABG) surgery. In a large, prospective, observational study of Ͼ5000 patients undergoing CABG surgery, pulse pressure Ն80 mm Hg was strongly associated with adverse postoperative outcomes including new neurologic events, new ischemic cardiac events, new congestive heart failure, and cardiac death. 8 It was also demonstrated that pulse pressure hypertension at progressively higher levels Ͼ40 mm Hg was a major risk factor for postoperative renal failure. 9 In a retrospective study of Ͼ900 CABG patients, increased baseline pulse pressure was associated with decreased long-term survival over approximately a 7-year period. 10 A prospective study of Ͼ1000 consecutive CABG patients found that baseline pulse pressure Ͼ70 mm Hg was positively associated with 30-day mortality, postoperative myocardial infarction, and new stroke or transient ischemic attack. 11 Finally, elevated pulse pressure was a major predictor of new stroke after CABG in a retrospective study of 703 patients. 12 In this study, patients with a baseline pulse pressure Ͼ72 mm Hg had lower stroke-free survival during a 1-year follow-up period.
Despite these findings, there are few data examining whether there is an association between increased pulse pressure and perioperative mortality after noncardiac surgery. The purpose of this study was to test the hypothesis that increased preoperative pulse pressure predicts 30-day and 1-year all-cause mortality after lower extremity arterial bypass surgery.
METHODS
The Mount Sinai School of Medicine IRB approved the study and waived the requirement of informed consent. All data were collected in a Health Insurance Portability and Accountability Act-compliant manner. A retrospective data review was performed on all patients who had infrainguinal arterial bypass procedures at our hospital between January 1, 2002 and January 1, 2008. Current Procedural Terminology codes for infrainguinal arterial bypass surgery were used to identify patients who met study criteria from our anesthesia department's electronic database. In our hospital, all patients have Current Procedural Terminology codes attached to their electronic anesthesia record and these codes are typically confirmed with the surgeon at the time of surgery. Only patients older than 18 years of age were included in the study. No patient was counted more than once in the analysis.
Blood Pressure Measurement
For each subject, a single arterial blood pressure was measured in the operating room using a noninvasive oscillometric blood pressure cuff before the administration of anesthetic medications or premedication. Mean arterial blood pressure, systolic blood pressure, and diastolic blood pressure were automatically recorded in the electronic anesthesia record system, CompuRecord (Philips Medical, Eindhoven, The Netherlands). All measurements were taken using 1 of 2 GE Healthcare/Datex-Ohmeda (Madison, WI) anesthesia machines (AISYS or ADU). Critikon blood pressure cuffs were used and were sized at the discretion of the anesthesiologist who performed the case. All cuffs were attached to a Datex-Ohmeda noninvasive blood pressure module. These modules are capable of recording blood pressures over the range of 25 to 260 mm Hg in an adult. According to the manufacturer, these devices meet or exceed the Association for the Advancement of Medical Instrumentation SP10 industry standard for noninvasive blood pressure measurement. There were no upgrades in technology at our center over the 6-year period, and all machines were serviced and calibrated at recommended intervals. Pulse pressure was calculated retrospectively for all subjects by subtracting diastolic blood pressure from systolic blood pressure using the data obtained from the electronic anesthesia record.
Data Collection
Medical data were collected from electronic hospital records and electronic anesthesia records for each patient. Specifically, we recorded the following: baseline serum creatinine Ͼ2.0 mg/dL, history of congestive heart failure, history of ischemic heart disease, history of cerebral vascular disease, history of diabetes mellitus (either insulin dependent or non-insulin dependent), Lee's Revised Cardiac Risk Index score, history of hypertension, history of dyslipidemia, ASA physical status, and indication for surgery. We also recorded preoperative medication use including aspirin, ␤-blockers, other preoperative antihypertensives, and "statin" drugs. Finally, we recorded whether the patient received general anesthesia or regional anesthesia for surgery.
Congestive heart failure was defined as a history of either systolic or diastolic heart failure confirmed with left ventricular function echocardiographic assessment. Ischemic heart disease was defined as having any of the following: electrocardiogram Q wave, nitrate use, previous CABG surgery or percutaneous coronary intervention, previous positive noninvasive test indicating myocardial ischemia, or previous non-Q wave myocardial infarction. Cerebral vascular disease was defined as a previous cerebral vascular accident, transient ischemic attack, or carotid endarterectomy. Hypertension was defined as a preoperative history of elevated systolic or diastolic blood pressure treated with antihypertensive medication. Dyslipidemia was defined as a preoperative history of elevated cholesterol or triglycerides treated with lipiddecreasing medication.
Indication for surgery was based on the Rutherford classification system and was separated into the following classes: claudication, rest pain, gangrene or ulcer, or other surgical indication. The Lee's Revised Cardiac Risk Index score was calculated by assigning 1 point for each of the following when present and then summing to determine a composite score: history of congestive heart failure, history of ischemic heart disease, history of cerebral vascular disease, baseline creatinine Ͼ2.0 mg/dL, and insulindependent diabetes mellitus. Infrainguinal arterial bypass surgery is not considered to be high-risk surgery in the Lee's scoring system and so the maximum possible score for all subjects was 5.
Outcome Variables
The primary outcome variables for the study were all-cause 30-day and 1-year mortality. Thirty-day mortality was defined as either death within 30 days of surgery or death before hospital discharge. Mortality data were obtained from hospital discharge summaries and by using the social security death index. All subjects were at least 1 year from the time of surgery when their social security number was checked against the social security death index.
Statistical Analysis
Preliminary review of the data indicated that the association between pulse pressure and 30-day and 1-year mortality appeared nonlinear and approximately "U shaped." Both low and high pulse pressures had a lower mortality rate, whereas the middle pulse pressures had a higher mortality rate. For this reason, we combined pulse pressures into 4 groups for statistical analysis: Յ40, 41 to 60, 61 to 80, and Ͼ80 mm Hg.
When estimating the statistical power of the study to determine whether high pulse pressure was associated with increased mortality, the evidence of a possible nonlinear association between pulse pressure and mortality was considered. Examples of mortality distributions that could provide 80% power against a linear or a nonlinear association, using a 2 test with a 0.05 significance level and given the sample sizes of our 4 pulse pressure groups are (0.02, 0.03, 0.03, 0.10) or (0.05, 0.03, 0.03, 0.10) for 30-day mortality. Comparable figures for 1-year mortality are (0.08, 0.12, 0.12, 0.23) or (0.20, 0.12, 0.12, 0.23).
The Kruskal-Wallis test was used to test the association between pulse pressure and age. 2 tests were used to test the association between pulse pressure and categorical variables, with the Cochran-Armitage test used when there was some evidence of a monotonic trend (e.g., diabetes, ASA physical status ՆIV, and regional anesthesia). Exact 2 tests were used to test the univariate associations between pulse pressure and 30-day and 1-year mortality. Preselected putative risk factors that were selected by the authors were then entered in a stepwise multiple logistic regression analysis. The variables considered in the stepwise procedure were pulse pressure, age, age Ն80 years (which was offered separately because preliminary analysis showed a high mortality rate in these groups of patients), ASA physical status ՆIV, Lee's Revised Cardiac Risk Index score, baseline creatinine Ͼ2.0 mg/dL, history of ischemic heart disease, history of cerebral vascular disease, insulin dependence, history of congestive heart failure, female gender, emergency surgery, dyslipidemia, diabetes, systolic or diastolic hypertension, type of anesthesia, indication for surgery, preoperative ␤-blocker use, preoperative clonidine use, preoperative angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use, preoperative calcium channel blocker use, preoperative diuretic use, preoperative statin use, preoperative aspirin use, and year of procedure. P values of Ͻ0.05 were considered statistically significant. Analyses were implemented using SAS software, version 9.2, and StatXact4 for Windows.
RESULTS
The distribution of blood pressure measurements in our subjects is summarized in Table 1 . The median systolic blood pressure was 161 mm Hg and median diastolic blood pressure was 82 mm Hg. The median pulse pressure was 77 mm Hg. There were 27 subjects with a pulse pressure Յ40 mm Hg; 86 subjects with a pulse pressure of 41 to 60 mm Hg; 199 subjects with a pulse pressure of 61 to 80 mm Hg; and 244 subjects with a pulse pressure Ͼ80 mm Hg.
Patient characteristics in each pulse pressure group are described in Table 2 . There was a significant association between pulse pressure and gender (P Ͻ 0.0001) with the highest pulse pressure group having the largest percentage of female patients. Higher pulse pressure was associated with increasing age (P Ͻ 0.0001). Diabetes and hypertension were common with increasing pulse pressure (P ϭ 0.04 and 0.09, respectively). Pulse pressure groups differed significantly by the percentage of patients receiving an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker and calcium channel blocker preoperatively (P ϭ 0.03 and 0.0001). There was an association between pulse pressure and ASA physical status with the lowest pulse pressure group having the highest percentage of patients with ASA physical status ՆIV. There were no associations between pulse pressure and the other listed preoperative variables.
The univariate relationship between pulse pressure and mortality is listed in Tables 3 and 4 . Our analyses showed no association between pulse pressure and 30-day or 1-year mortality regardless of how pulse pressure was dichotomized. Thirty-day mortality for the cohort was 5.1% with higher mortality noted for patients with pulse pressure between 41 to 60 mm Hg (7.0%) and 61 to 80 mm Hg (6.5%) compared with patients in the lowest and highest pulse pressure groups, Յ40 mm Hg (3.7%) and Ͼ80 mm Hg (3.3%), respectively (P ϭ 0.35). One-year mortality for the cohort was 17.8% with the highest 1-year mortality occurring in patients with a pulse pressure of 61 to 80 mm Hg (22.1%) and the lowest 1-year mortality occurring in patients with a pulse pressure Ͻ40 mm Hg (7.4%) (P ϭ 0.14).
One-year survival curves for pulse pressure groups are shown in Figure 1 .
The results of stepwise multivariate logistic regression analysis for 30-day and 1-year mortality are shown in Tables 5 and 6. Four factors were independently associated with 30-day mortality: baseline creatinine Ͼ2.0 mg/dL, age Ն80 years, ASA physical status ՆIV, and emergency surgery. There were 7 variables independently associated with 1-year mortality: Lee's Revised Cardiac Risk Index score, age, ASA physical status ՆIV, emergency surgery, female gender, indication for surgery, and baseline creatinine Ͼ2.0 mg/dL. Box plots showing the model predicted likelihood of 1-year mortality by pulse pressure group are shown in Figure 2 .
DISCUSSION
We found no apparent association between increased preoperative pulse pressure and 30-day or 1-year all-cause mortality in a cohort of 556 patients having lower extremity arterial bypass surgery. Age Ն80 years, ASA physical status ՆIV, emergency surgery, and baseline creatinine Ͼ2.0 mg/dL were independently associated with 30-day mortality. The same variables were associated with 1-year mortality, as were female gender, the Revised Cardiac Risk Index score, and gangrene or ulcer as an indication for surgery.
Pulse pressure hypertension has been identified as a risk factor for cardiovascular morbidity and mortality in large population-based studies. [2] [3] [4] [5] [6] [7] In a study of Ͼ12,000 middleaged men, the age-adjusted hazard ratio for cardiovascular mortality is 1.19 to 1.29 for every 10 mm Hg increase in pulse pressure. 3 Elevated pulse pressure is also associated with new onset congestive heart failure and new coronary artery disease in elderly patients in a linear and independent manner. 6 When compared with mean and systolic blood pressure, pulse pressure yields the strongest association. 6 Pulse pressure hypertension has also been identified as a risk factor for mortality, renal failure, cardiovascular complications, and stroke after cardiac surgery. 8 -12 Specifically, pulse pressure increments of 10 mm Hg above a threshold of 40 were associated with new cerebral events and above 80 mm Hg were associated with cardiac complications and death. 8 Few studies, however, have examined pulse pressure hypertension as a perioperative risk factor in noncardiac surgery and our results suggest that it might not be associated with mortality after other types of high-risk surgery.
Elevated pulse pressure is the result of multiple changes in the walls of central arteries that result in a general "stiffening" of the blood vessel. 13 Normally, arterial waves generated from left ventricular ejection return to the central circulation during diastole augmenting diastolic myocardial perfusion. In the presence of vascular stiffening, these waves return earlier during systole resulting in increased systolic pressure and decreasing diastolic pressure. The early return of reflected pressure waves may contribute to myocardial dysfunction by increasing left ventricular afterload. 14 Furthermore, the decreased arterial pressure during diastole may decrease coronary perfusion pressure predisposing to ischemia. Arterial stiffening may also lead to arteriolar adaptive changes in highly perfused organs such as the brain and kidney including the formation of microaneurysms and dilations, lipohyalinosis, and fibroid necrosis of the vessel wall. 15 The brain and kidneys are unique organs in that they are continually and passively perfused at high-volume flow throughout systole and diastole. 15 The relatively low vascular resistances of these organs make them particularly susceptible to injury when there is stiffening of the upstream arterial tree. 15 Differences in our results with those reported from patients undergoing CABG surgery are notable. For example, in a study of 5000 patients undergoing CABG, pulse pressure was linked with cardiovascular complications, renal failure, stroke, and death. 8 In that study, the mean systolic, mean diastolic, and mean pulse pressure (134 mm Hg, 75 mm Hg, and 59 mm Hg, respectively) were higher than in our cohort (161 mm Hg, 83 mm Hg, and 79 mm Hg, respectively). Moreover, a larger percentage of our patients were categorized in the highest pulse pressure group than the CABG surgery patients (43.9% with pulse pressure Ͼ80 mm Hg vs 8%). This finding might be explained by a frequent prevalence of end-stage vascular disease manifested as tissue loss in our study. We also had an increased prevalence of comorbid disease as compared with the CABG cohort. For example, in our study, the prevalence of These factors were selected in a stepwise logistic regression procedure in which all the factors shown in Table 2 , as well as year of procedure, were offered. The c-index for this model was 0.84. Note: Pulse pressure was not selected in the stepwise procedure and was not statistically significant (P ϭ 0.28) when the 4 groups (Յ40 mm Hg, 41-60 mm Hg, 61-80 mm Hg, and Ͼ80 mm Hg) were tested as a fifth factor in the above model. These factors were selected in a stepwise logistic regression procedure in which all the factors shown in Table 2 , as well as year of procedure, were offered. The c-index for this model was 0.82. Note: Pulse pressure was not selected in the stepwise procedure, and was not statistically significant (P ϭ 0.32) when the 4 groups (Յ40 mm Hg, 41-60 mm Hg, 61-80 mm Hg, Ͼ80 mm Hg) were tested as an eighth factor in the above model.
diabetes was 64% and cerebral vascular disease was 17% compared with rates of 30% and 11% in the CABG surgery study. Another difference between our study and previous studies in cardiac surgery patients is that we calculated pulse pressure retrospectively from a single oscillometric noninvasive blood pressure cuff reading that was taken in the operating room. In most previous studies, a mean pulse pressure was calculated from multiple blood pressure readings outside the operating room. Many of our patients were admitted on the day of surgery precluding multiple preoperative blood pressure measurements. Also, the electronic medical record that we use does not contain outpatient blood pressure measurements for comparison. Using a single operating room blood pressure measurement to determine pulse pressure is a limitation of our study. Our decision to use oscillometric blood pressure cuff measurements was based on the fact that most patients had arterial catheters placed after the induction of general anesthesia and we did not want pulse pressure to be influenced by the effects of anesthetic drugs. Oscillometric blood pressure cuff readings are most accurate in measuring mean arterial pressure, which occurs at the point of maximum oscillation. Typically, both systolic and diastolic blood pressure must be derived using manufacturerspecific algorithms. Alternatively, arterial catheters measure both systolic and diastolic blood pressure directly and this may allow for a more accurate determination of pulse pressure. Nevertheless, oscillometric cuffs are widely used in clinical practice and have been recommended for monitoring intraoperative blood pressure by the American Heart Association. 16 In our study, the blood pressure of all subjects was measured using identical technology, which meets or exceeds industry standards. It is possible, however, that some blood pressure cuffs were not appropriately sized and this is a limitation. When oscillometric cuffs are inappropriately sized, especially in critically ill patients, their measurements have been found to differ significantly from invasive blood pressure measurements. 17 All blood pressure cuffs in our study were placed and sized at the discretion of the attending anesthesiologist and in our hospital there is no standardized protocol for sizing cuffs.
Our study may also have some misclassification of subjects because of the tendency for preoperative anxiety and catecholamine release to increase blood pressure in the operating room. This might account in part for the higher percentage of patients with pulse pressure Ն80 mm Hg in our cohort. It could also reduce mortality in the high pulse pressure group if patients who did not truly have chronic pulse pressure hypertension were misclassified into that group.
In our study, we evaluated the relationship between pulse pressure and all-cause 30-day and 1-year mortality in vascular surgery patients. Vascular surgery patients may have more modest hemodynamic perturbations during the perioperative period than cardiac surgery patients because they do not require cardiopulmonary bypass and thus arterial stiffening may not be as significant a risk factor for perioperative mortality after this type of surgery. We also did not have data on the specific cause of death. Most short-term mortality in vascular surgery patients occurs because of cardiovascular complications. 18 -21 Nevertheless, it is likely that some deaths occurred secondary to cancer, sepsis, or other causes, and this could explain in part the difference in our findings compared with previous studies that used cardiovascular morbidity and mortality as their primary outcome variables.
In conclusion, we found no apparent association between increased preoperative pulse pressure and 30-day or 1-year all-cause mortality in patients having lower extremity arterial bypass surgery. The variables that were independently associated with both 30-day and 1-year mortality in our study are consistent with prior studies. [22] [23] [24] [25] Future prospective studies are necessary to clarify the association between pulse pressure and perioperative mortality in noncardiac, high-risk surgical patients.
